Hengrui Pharmaceutical announced that on August 14, the company used centralized bidding transactions to repurchase 488,000 A shares, accounting for 0.008% of the number of shares currently issued before the incident, to be used for A-share employee stock ownership plans. The repurchase price per share ranged from $52.4 to $53.2, and the total price paid was 257.996 million yuan. As of August 14, the total number of shares issued by the company was 6.379 billion shares and 11.4313 million shares in treasury.

Hengrui Pharmaceutical announced that on August 14, the company used centralized bidding transactions to repurchase 488,000 A shares, accounting for 0.008% of the number of shares currently issued before the incident, to be used for A-share employee stock ownership plans. The repurchase price per share ranged from $52.4 to $53.2, and the total price paid was 257.996 million yuan. As of August 14, the total number of shares issued by the company was 6.379 billion shares and 11.4313 million shares in treasury.